The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 As per The Business Research Company’s Endometrial Cancer Treatment Global Market Report 2023, the global endometrial cancer treatment market size is expected to grow from $28.55 billion in 2022 to $29.90 billion in 2023 at a compound annual growth rate (CAGR) of 4.72%. The global endometrial cancer treatment market size is expected to reach $36.52 billion in 2027 at a CAGR of 5.13%.

What was the major driver in the endometrial cancer treatment market?
The growing prevalence of endometrial cancer is expected to propel the growth of the endometrial cancer treatment market going forward. The prevalence of endometrial cancer refers to an increase in the number of cases of endometrial cancer within a specific population or over a certain period. This shift has resulted from changes in risk factors, improved detection and diagnosis methods, increased awareness, and an aging population. Endometrial cancer treatments help in early endometrial cancer detection, providing targeted therapies, prevention of recurrence, and clinical trials and research studies to improve treatment options. As the prevalence of endometrial cancer continues to rise and advancements in treatment options expand, the endometrial cancer treatment market is expected to grow. For instance, in March 2022, according to World Cancer Research Fund International, a UK-based cancer prevention association, 2020 endometrial cancer was the 6th most commonly occurring cancer in women affecting around 417,367 women across the globe and causing 97,370 deaths in 2020. Poland has the highest rate of prevalence of endometrial cancer affecting around 9,869 women across the country. Therefore, the rise in prevalence of endometrial cancer is driving the growth of the endometrial cancer treatment market.

View More On The Endometrial Cancer Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/endometrial-cancer-treatment-global-market-report

What was the key trend in the endometrial cancer treatment market?
Technological advancements in endometrial cancer diagnosis and treatment are a key trend gaining popularity in the endometrial cancer treatment market. Companies operating in the market are launching technologically advanced endometrial cancer diagnoses and treatments to sustain their position in the market. For instance, in April 2022, Roche Holding AG received FDA approval for VENTANA MMR RxDx Panel endometrial cancer diagnostic kit to diagnose patients eligible for anti-PD1 immunotherapy that is treatment with JEMPERLI (dostarlimab-gxly) monotherapy. This test is an effective tool for clinicians for patient diagnosis and providing new treatment options to women having MMR-deficient endometrial cancer during or after chemotherapy treatment.

Which was the largest region in the endometrial cancer treatment market?
North America was the largest region in the endometrial cancer treatment market in 2022. The regions covered in the global endometrial cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the endometrial cancer treatment market prominent players?
Major players in the endometrial cancer treatment market are Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC., F. Hoffmann-La Roche AG, Siemens Healthcare GmbH, Merck & Co. Inc., Sanofi-Aventis, Ariad Pharmaceuticals Inc., Becton, Dickinson And Company, Teva Pharmaceutical Industries Limited, AstraZeneca PLC., Pfizer Inc., Bristol-Myers Squibb Company, Celgene Corp and Eisai Co. Ltd. The countries covered in the endometrial cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA,

Key endometrial cancer treatment market segments
1) By Type: Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types
2) By Diagnosis Method: Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods
3) By Route Of Administration: Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Request A Sample Of The Global Endometrial Cancer Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10735&type=smp

The Endometrial Cancer Treatment Global Market Report 2023 provides a comprehensive overview on the endometrial cancer treatment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Cancer Diagnostics Global Market Report 2023
Cancer Monoclonal Antibodies Global Market Report 2023
Cancer Clinical Decision Tools Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model